Quantum-Si Inc

Quantum-Si Incorporated (Nasdaq: CAPA) is a life sciences technology company that completed its de-SPAC business combination with HighCape Capital Acquisition Corp. in 2021, with HighCape Capital serving as the transaction's sponsor. The company develops proprietary semiconductor chip-based sequencing instruments targeting the genomics and proteomics research market, with its Platinum platform designed to enable single-molecule protein sequencing. Quantum-Si has remained publicly traded on Nasdaq since its merger and filed an 8-K with the Securities and Exchange Commission on May 19, 2025. For comprehensive filings history, deal analytics, and real-time data on Quantum-Si and thousands of other SPAC transactions, sign up for full access at SpacDesk.